2,851
edits
Nicotinamide Adenine Dinucleotide (NAD): Difference between revisions
Nicotinamide Adenine Dinucleotide (NAD) (view source)
Revision as of 10:34, 11 December 2023
, 11 December 2023no edit summary
(→Todo) |
No edit summary |
||
| Line 37: | Line 37: | ||
* The effective dosages and potential side effects. | * The effective dosages and potential side effects. | ||
* The real impact on human longevity. | * The real impact on human longevity. | ||
== See also == | == See also == | ||
| Line 49: | Line 43: | ||
* [[NADase]] | * [[NADase]] | ||
* [[wikipedia:Nicotinamide adenine dinucleotide|Wikpedia article]] | * [[wikipedia:Nicotinamide adenine dinucleotide|Wikpedia article]] | ||
== Todo == | |||
*{{pmid text|33353981}} | |||
*{{pmid text|35665345}} | |||
*{{pmid text|35010977}} | |||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Other Longevity Compounds]] | [[Category:Other Longevity Compounds]] | ||
[[Category:Molecular and Cellular Biology]] | [[Category:Molecular and Cellular Biology]] | ||